WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine
WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine
The global platform for access to childhood cancer medicines
Cancer medicine shortages for children around the world
OncoAlert and ecancer round up: SABCS 2021
INTEGRATE study: Treatment pathways, outcomes and resource use in patients with multiple myeloma
Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic
Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients
Tisagenlecleucel shows no EFS improvement on standard of care in 2L for aggressive B-cell NHL
Integrated genomic analysis identifies UBTF tandem duplications as a subtype-defining lesion in paediatric AML
Asciminib found to be safe and effective for heavily pretreated patients with chronic myeloid leukaemia in chronic phase
Long-term OS benefit with oral azacitidine for acute myeloid leukaemia in first remission after intensive chemo
Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL